Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin

被引:20
作者
Drieschner, N. [1 ]
Belge, G. [1 ]
Rippe, V. [1 ]
Meiboom, M. [1 ]
Loeschke, S. [1 ]
Bullerdiek, J. [1 ]
机构
[1] Univ Bremen, Ctr Human Genet, D-28359 Bremen, Germany
关键词
D O I
10.1089/thy.2006.16.1091
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Epithelial tumors of the thyroid are cytogenetically well-investigated tumors. So far, the main cytogenetic subgroups, characterized by trisomy 7 and by rearrangements of either 19q13 or 2p21, respectively, have been described. Recently, we have been able to describe the involvement of a novel gene called THADA in benign thyroid lesions with 2p21 rearrangements. Other fusion genes found in thyroid lesions are RET/PTC and PAX8/PPAR gamma. The latter occurs in follicular thyroid carcinomas with a t(2;3)(q13;p25). Here we present molecular-cytogenetic and cytogenetic investigations on a follicular thyroid adenoma with a t(2;20;3)(p21;q11.2; p25). In this case, an intronic sequence of PPAR gamma is fused to exon 28 of THADA. We used BAC clones containing the genomic sequence of PPAR gamma for fluorescence in situ hybridization to confirm the localization of the breakpoint within intron 2 of PPAR gamma. Our findings suggest that the close surrounding of PPAR is a breakpoint hot spot region, leading to recurrent alterations of this gene in thyroid tumors of follicular origin including carcinomas as well as adenomas with or without involvement of PAX8.
引用
收藏
页码:1091 / 1096
页数:6
相关论文
共 40 条
  • [11] ABERRATIONS OF CHROMOSOME-8 IN MIXED SALIVARY-GLAND TUMORS - CYTOGENETIC FINDINGS ON 7 CASES
    BULLERDIEK, J
    BOSCHEN, C
    BARTNITZKE, S
    [J]. CANCER GENETICS AND CYTOGENETICS, 1987, 24 (02) : 205 - 212
  • [12] Detection of the PAX8-PPARγ fusion oncogene in both follicular thyroid carcinomas and adenomas
    Cheung, L
    Messina, M
    Gill, A
    Clarkson, A
    Learoyd, D
    Delbridge, L
    Wentworth, J
    Philips, J
    Clifton-Bligh, R
    Robinson, BG
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) : 354 - 357
  • [13] TRANSLOCATION (5-19)(Q13-Q13) IN A MULTINODULAR THYROID GOITER
    CIGUDOSA, JC
    GUERRA, AP
    GOMEZ, AO
    JUAN, JLC
    GOMEZ, JAP
    ROCA, OF
    MIRANDA, JLG
    [J]. CANCER GENETICS AND CYTOGENETICS, 1995, 82 (01) : 67 - 69
  • [14] Involvement of the PAX8/peroxisome proliferator-activated receptor γ rearrangement in follicular thyroid tumors
    Dwight, T
    Thoppe, SR
    Foukakis, T
    Lui, WO
    Wallin, G
    Höög, A
    Frisk, T
    Larsson, C
    Zedenius, J
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (09) : 4440 - 4445
  • [15] A nuclear receptor in thyroid malignancy:: is PAX8/PPARγ the Holy Grail of follicular thyroid cancer?
    Führer, D
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 144 (05) : 453 - 456
  • [16] Greene M. E., 1995, Gene Expression, V4, P281
  • [17] CYTOGENETIC STUDY OF A PAPILLARY THYROID-CARCINOMA WITH A REARRANGED CHROMOSOME-10
    HERRMANN, ME
    MOHAMED, A
    TALPOS, G
    WOLMAN, SR
    [J]. CANCER GENETICS AND CYTOGENETICS, 1991, 57 (02) : 209 - 217
  • [18] JENKINS RB, 1990, CANCER-AM CANCER SOC, V66, P1213, DOI 10.1002/1097-0142(19900915)66:6<1213::AID-CNCR2820660622>3.0.CO
  • [19] 2-9
  • [20] Evaluation of peroxisome proliferator-activated receptor-γ expression in benign and malignant thyroid pathologies
    Karger, S
    Berger, K
    Eszlinger, M
    Tannapfel, A
    Dralle, H
    Paschke, R
    Führer, D
    [J]. THYROID, 2005, 15 (09) : 997 - 1003